The Longevity Bulletin aims to provide a regular overview of research on some of the biggest challenges facing Government and society in the context of longevity, ageing and population change

The Longevity Bulletin is published twice a year and it presents and explains actuarial perspectives on population longevity and looks beyond the actuarial world for statistics, research and the latest thinking on related subjects. Each publication provides general and technical perspectives to best address relevant longevity topics.

Latest editions

Big data in health, December 2016

Issue 9 – Big data is now being used to predict epidemics, cure diseases, improve quality of life and avoid preventable deaths. In other words it provides new measurement capabilities for doctors but also for insurers, regulators and even patients themselves. This Longevity Bulletin presents a number of theoretical and practical examples on the uses of big data. It also outlines some of the world-class research activities and goes into detail on the challenges from using biomedical data.





Antimicrobial Resistance edition, May 2016

Issue 8 – Antimicrobial resistance (AMR) is perceived as a growing threat to health and well-being globally. Drug-resistant infections are estimated to cause 10 million deaths a year and cost up to £66 trillion by 2050. This edition of the Longevity Bulletin examines the clinical implications, impacts on longevity and the potential economic cost of current trends in AMR. It also goes into detail on new research and discoveries in creating new antibiotics.





Modelling edition, November 2015

Issue 7 - The last century had seen significant improvements in mortality rates and the continuing increase in life expectancy have brought to the fore the critical importance of longevity modelling. This Longevity Bulletin focuses on how different modelling techniques can be used to more accurately track longevity trends. It also explores some of the reasons why we are living longer, identifies causes of ageing, but also looks at the possibility of drugs being designed to treat ageing.





Subscribe to the Longevity Bulletin

Related documents

Contact Details

For more information about the Longevity Bulletin please contact the Research and Knowledge Team.